Ureteroscopy in Patients Taking Anticoagulant or Antiplatelet Therapy: Practice Patterns and Outcomes in a Surgical Collaborative
- 9 October 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 205 (3), 833-840
- https://doi.org/10.1097/ju.0000000000001416
Abstract
Purpose: AUA guidelines recommend ureteroscopy (URS) as first-line therapy for patients on anticoagulant (AC) or antiplatelet (AP) therapy, and advocate using a ureteral access sheath (UAS). We examined practice patterns and unplanned healthcare utilization in these patients in Michigan. Materials and Methods: Using the Michigan Urological Surgery Improvement Collaborative (MUSIC) clinical registry, we identified URS cases from 2016 to 2019. We assessed outcomes and adherence to guidelines based on therapy at time of URS: (1) AC: continuous warfarin or novel oral agent therapy, (2) AP: continuous clopidogrel or aspirin therapy, (3) Control: not on AC/AP therapy. We fit multivariate models to assess AC or AP therapy association with emergency department (ED) visits, hospitalization, and UAS use. Results: In total, 9982 URS were performed across 31 practices, with 3.1% and 7.8% on AC and AP therapy, respectively. There was practice (0-21%) and surgeon (0-35%) variation in performing URS on AC/AP, regardless of volume. After adjusting for risk factors, AC or AP therapy was not associated with ED visits. Hospitalization rates in AC, AP, and control groups were 4.3%, 5.5%, and 3.2%, respectively, and significantly increased with AP therapy (OR 1.48, 95% CI: 1.02–2.14). Practice-level UAS use varied (23-100%), and was not associated with AC/AP therapy. Limitations include inability to risk stratify between type/dosage of AC/AP therapy. Conclusions: We found practice and surgeon-level variation in performing URS while on AC/AP therapy. URS on AC is safe, however AP therapy increases the risk of hospitalization. Despite guideline recommendations, UAS use is not associated with AC/AP therapy.Keywords
This publication has 13 references indexed in Scilit:
- Ureteroscopy in Patients with Bleeding Diatheses, Anticoagulated, and on Anti-Platelet Agents: A Systematic Review and Meta-Analysis of the LiteratureJournal of Endourology, 2017
- Direct oral anticoagulants: analysis of worldwide use and popularity using Google TrendsAnnals of Translational Medicine, 2017
- The Effect of Anticoagulation on Bleeding-related Complications Following UreteroscopyUrology, 2017
- The Effect of Antiplatelet Agents on Bleeding-Related Complications After UreteroscopyJournal of Endourology, 2016
- Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART IJournal of Urology, 2016
- The Effect of Antiplatelet and Anticoagulant Therapy on the Clinical Outcome of Patients Undergoing UreteroscopyUrology, 2013
- Ureteroscopy in patients with coagulopathies is associated with lower stone-free rate and increased risk of clinically significant hematuria.International braz j urol, 2012
- Safety and Efficacy of Flexible Ureterorenoscopy and Holmium:YAG Lithotripsy for Intrarenal Stones in Anticoagulated CasesJournal of Urology, 2008
- Risk of Thromboembolism With Short-term Interruption of Warfarin TherapyArchives of Internal Medicine, 2008
- Prevention of Premature Discontinuation of Dual Antiplatelet Therapy in Patients With Coronary Artery Stents: A Science Advisory From the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, With Representation From the American College of PhysiciansJournal of the American College of Cardiology, 2007